Professor Jonathan Waxman

Medical oncology


  • Not Fee assured

About me

Jonathan Waxman is Professor of Oncology at the Hammersmith Hospital, London. He is the author of around 400 research papers and chapters, on a variety of cancers, and of eleven books on cancer. He practises as a general oncologist, treating patients with a wide range of malignancies. He specialises in urological oncology treating patients with prostate, kidney, bladder and testicular cancer and has developed new treatments for these conditions such as LHRH agonist therapy for prostate cancer..

He has raised funds for the building of the Hammersmith Cancer Centre whose spirit aims to combine the best of conventional and alternative therapies. He founded Prostate Cancer UK, the first United Kingdom national organisation promoting research and patient support for this condition. He helped establish an All Party Parliamentary Group to improve cancer treatment and rationalise cancer research throughout the UK

Professor Waxman is an oncologist in general solid tumour practice, running laboratory and clinical research programmes. The third edition of his medical student reference book on oncology, entitled ‘Lecture Notes on Oncology’, will be published in 2014.

Areas of interest

Prostate disease including prostate cancer
Urological malignancies, prostate, kidney, bladder, testicular

Medical secretaries

My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

    London Clinic (1-5) HCA - The London Oncology Clinic LLP (1-5)

  • X0001

    Clinical supervision and planning for the delivery of chemotherapy regimens for 0 to 7 days - (1-5)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.